Cognitive Dysfunction clinical trials
The registry lists 3,872 studies for Cognitive Dysfunction across more than 10 countries. 1,119 are recruiting or about to start. 1,911 of them are mainly about Cognitive Dysfunction (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-10. Counting its 2 narrower conditions too, such as Postoperative Cognitive Complications: 4,122 studies, 1,178 open.
ClinicalTrials.gov finds 5,333 studies for Cognitive Dysfunction. How that becomes 3,870 here
This page counts the studies the registry files under Cognitive Dysfunction, and those it files under no condition that list Cognitive Dysfunctionthemselves. Each study its search finds is placed by how the registry filed it and by the conditions it lists. ClinicalTrials.gov counts as of Nov 8, 2026. How condition pages count
- 5,333Found by its condition searchIt reads the conditions a study lists and their synonyms, and also titles and keywords.
- −250Filed under a narrower condition, counted on its own pagePostoperative Cognitive Complications 221 · Chemotherapy-Related Cognitive Impairment 26
- −85List Cognitive Dysfunction as a condition, but the registry did not file them under itMost often written as “Vascular Cognitive Impairment” (14), “Amnestic Mild Cognitive Impairment” (7), and “Post-stroke Cognitive Impairment” (6). The registry filed them under other conditions only, most often Alzheimer Disease (25) and Stroke (13).
- −1,131Match it another way491 name it in the title, 45 in a keyword, and 595 by a synonym or other text the search reads.
- 3,867Counted here and found by its search81 of them list Cognitive Dysfunction in their own words; the registry filed them under no condition.
- +3
Counted here, but its search does not find them
- Study of MRI 3Tesla Infusion Without Arterial Spin Labeling Injection (ASL) in Cognitive Atypical and Comparison to the FDG-PETNCT02058043
- Brief Intervention for FCD: A Feasibility StudyNCT07379723
- Study on the Correlation Between Treg Immune Cells on the Muscle Content and Cognitive Functions of the ElderlyNCT06493669
- 3,870The count on this page
Get an email when these change. Save the Cognitive Dysfunction studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Status
Who runs them
VA Office of Research and Development (35) · Johns Hopkins University (34) · University of California, San Francisco (32) · Massachusetts General Hospital (32) · Wake Forest University Health Sciences (28) · Chang Gung Memorial Hospital (26) · University of Pennsylvania (24) · Emory University (24)
What is being tested here
Drugs under test in Cognitive Dysfunction studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted
| Drug | Open | Phase 3 | All |
|---|---|---|---|
| Dexmedetomidine | 4 | 0 | 12 |
| Metformin | 3 | 2 | 10 |
| Ginkgo biloba extract | 3 | 1 | 7 |
| Lacteol | 3 | 0 | 3 |
| Memantine | 2 | 5 | 15 |
| Insulin | 2 | 1 | 11 |
| Methylphenidate | 2 | 1 | 7 |
| Nicotinamide-beta-riboside | 2 | 0 | 6 |
| Melatonin | 2 | 0 | 4 |
| Atorvastatin | 2 | 0 | 3 |
Drug classes tested here Cholinesterase inhibitors 4 open · Stimulants 4 open · SGLT2 inhibitors 3 open · Antimuscarinics 3 open · Reverse transcriptase inhibitors 2 open
Coming up
Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.
The 10 nearest, phase 3 first
- Dec 2026Biomarker Exploration in Aging, Cognition and Neurodegeneration · Phase 3 · University of California, Irvine
- Dec 2026A Study to Confirm Safety and Efficacy of Lecanemab in Participants With Early Alzheimer's Disease · Phase 3 · Eisai Inc.
- Jan 2027MitoQ for Early-phase Schizophrenia-spectrum Disorder and Mitochondrial Dysfunction · Phase 3 · Mclean Hospital
- Feb 2027Effect of a Multidomain Intervention Plus Turmeric on the Prevention of Cognitive Decline in People Over 55 Years of Age With Insulin Resistance. · Phase 3 · Instituto Mexicano del Seguro Social
- Feb 2027Evaluating Cognitive Changes on Patients in Chemotherapy (ECCPC) · Phase 3 · Ellis Medicine
- Nov 2027Effect of Metformin on Behaviour and the Brain in Children Treated for a Brain Tumour · Phase 3 · Donald Mabbott
- Nov 2026Multi-Center Development of a Novel Diagnostic Test for Alzheimer's Disease · Boston University
- Nov 2026Effects of tDCS on Cognitive Function in Older Adults With Subjective Cognitive Decline: Randomized Sham-Controlled Trial · Universidad Autónoma del Estado de Hidalgo
- Nov 2026Blood Biomarkers for Early and Accurate Diagnosis of Alzheimer's Disease in Primary Care · Imperial College London
- Nov 2026Dyadic Management Intervention in Older People With Co-occurring Cognitive Impairment and Diabetes as a Supplementary Approach to Chronic Diseases Self-Management Program · The Hong Kong Polytechnic University
Who these studies take
Of the 750 Cognitive Dysfunction studies recruiting now, 362 (48%) set no upper age limit and 143 (19%) stop at 75 or younger. 46 (6%) take children under 18. 16 (2%) are for women only and 1 (<1%) for men only; 259 (35%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 33 (4%) | 31 (4%) |
| 18 | 238 (32%) | 231 (31%) |
| 30 | 264 (35%) | 255 (34%) |
| 40 | 305 (41%) | 293 (39%) |
| 50 | 439 (59%) | 426 (57%) |
| 65 | 684 (91%) | 672 (90%) |
| 75 | 655 (87%) | 646 (86%) |
| 85 | 532 (71%) | 523 (70%) |
Across all 3,872 studies, recruiting or not: 21% stop at 75 or younger and 13% at 65; 5% take children; 3% are for women only and 1% for men only; 35% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
How long Cognitive Dysfunction studies take
Of 186 phase 2 interventional studies under Cognitive Dysfunction, half reached primary completion within 44 months of starting, counting those still running.
| Start to primary completion | Every sponsor | Industry | Non-industry |
|---|---|---|---|
| Phase 1 | 27 mo13–49 · 80 studies | 17 mo7–40 · 26 studies | 43 mo16–64 · 54 studies |
| Phase 1/2 | 34 mo12–52 · 25 studies | — | — |
| Phase 2 | 44 mo22–62 · 186 studies | 24 mo14–39 · 41 studies | 53 mo29–64 · 145 studies |
| Phase 3 | 44 mo33–63 · 49 studies | — | — |
| Phase 4 | 55 mo20–69 · 51 studies | — | 55 mo27–69 · 43 studies |
| Interventional, no phase | 27 mo12–50 · 1,511 studies | 15 mo7–35 · 69 studies | 27 mo13–51 · 1,442 studies |
| Observational | 47 mo21–118 · 543 studies | — | 49 mo22–118 · 504 studies |
Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out
What changed recently
From the registry's own updates since Oct 11, 2026.
Started recruiting10
- Locus Coeruleus and CCHS (Congenital Central Hypoventilation Syndrome)Nov 6, 2026NCT07081464
- Feasibility of A Smartphone Application Intervention in Community Settings: A Pretest-Posttest Pilot StudyNov 5, 2026NCT07313540
- Flutemetamol F 18 Injection Formulation ComparisonNov 5, 2026NCT07873463
- Oral Motor and Cognitive Dual-Task Training (OMCDT) Program for Improving Oral and Cognitive Functions Among People With Oral FrailtyNov 3, 2026NCT07733726
- HOBSCOTCH-YOUTH and Young AdultsNov 2, 2026NCT07735715
Show 5 moreShow fewer
- Loneliness as Risk Factor for DementiaOct 28, 2026NCT07211945
- Use of Wearables for Identifying Factors Associated With Mild Cognitive Impairment and Early-Stage Alzheimer's DiseaseOct 22, 2026NCT07391436
- Choose Myself (Before) Losing MyselfOct 22, 2026NCT07846566
- Eye Movement Parameters and Cognitive Functions in Older AdultsOct 15, 2026NCT07358598
- CMN LIFU for Enhanced Amyloid Reduction (CLEART Study)Oct 14, 2026NCT07866768
Results posted4
- Modulation Effects of Baduanjin Exercise on Subjective Cognitive DeclineNov 6, 2026NCT04009382
- A Study of JNJ-63733657 in Participants With Early Alzheimer's DiseaseNov 5, 2026NCT04619420
- Network-guided TMS in Early Alzheimer's DiseaseOct 27, 2026NCT04549155
- Home-based tDCS in Frontotemporal Dementia or Alzheimer's DiseaseOct 21, 2026NCT05978804
Stopped4
- A Study Evaluating the Efficacy of Xanomeline/Trospium (XT) on Cognitive Impairment After 24 and 52 Weeks of Treatment in Adult Participants With SchizophreniaWithdrawnOct 30, 2026NCT07084831
- Electrophysiological Signatures of Cognitive Disorders Related to Intensive Care Unit (ICU) delirium_ BRAINSTORM-EEGTerminatedOct 29, 2026NCT06089538
- Surviving Daily LifeTerminatedOct 28, 2026NCT07054723
- Adaptation and Normalization of a Verbal Episodic Memory Test in French Sign LanguageSuspendedOct 16, 2026NCT06902753
Newly registered33
- Effect of Long-Term Head and Neck Venous Outflow Obstruction on Cognitive Function: Evidence From Patients With Internal Jugular Vein StenosisNov 10, 2026NCT07927361
- Temporal Interference Stimulation Targeting Thalamus for Schizophrenia-Related Cognitive DysfunctionNov 10, 2026NCT07927790
- Prospective Research on Identification of Dementia in Early Stages (P.R.I.D.E)Nov 5, 2026NCT07918638
- The Effects of Fine Motor Training With Augmented Reality on the Memory of Older Adults With Amnestic Mild Cognitive ImpairmentNov 4, 2026NCT07915583
- Chinese University-Alzheimer's Disease With Vascular and Other Co-pathology: Towards Actionable Neuro-Cognitive-Omic Evaluations (CU-ADVANCE)Nov 4, 2026NCT07917182
Show 28 moreShow fewer
- China HEalthy Aging and Dementia Study (HEAD)Nov 3, 2026NCT07912710
- BioMIND Biospecimen RepositoryNov 3, 2026NCT07912736
- Transcranial Direct Current Stimulation for Chemotherapy-Related Chronic Pain in Cancer SurvivorsNov 3, 2026NCT07912775
- Small Monetary Incentives for Digital Cognitive Training Adherence in Community-Dwelling Older AdultsNov 3, 2026NCT07913243
- Rural Veteran and Care Partner Walking ProgramNov 3, 2026NCT07914218
- A Prospective Study of Cognitive Changes in Retired and Late-Career Professional Soccer PlayersNov 2, 2026NCT07910994
- EEG Markers From Polysomnography and Cognitive Performance in Obstructive Sleep ApneaOct 27, 2026NCT07897474
- Detecting and Predicting Post-stroke Cognitive Impairment Using the Oxford Cognitive ScreenOct 27, 2026NCT07897916
- Development and Validation of Risk Prediction Models for Stroke and Cognitive Impairment in Moyamoya Disease and Moyamoya SyndromeOct 26, 2026NCT07894107
- Fuzhou Aging Brain Health InitiativeOct 23, 2026NCT07891429
- Postsurgical Pain and Opioid Use in Older Adults: Effects of Mild Cognitive ImpairmentOct 21, 2026NCT07885085
- Deep Brain Stimulation Guided by Brain Mapping to Treat Cognitive ImpairmentOct 21, 2026NCT07887737
- Physical Performance and Cognitive Functions in Patients With Chronic StrokeOct 21, 2026NCT07887776
- Clinical Significance of Internal Carotid Artery DolichoarteriopathyOct 20, 2026NCT07882875
- Effects of Tadalafil on Cognition and Cerebral Hemodynamics in Elderly Patients With Mild Cognitive ImpairmentOct 20, 2026NCT07882901
- TPSAlz - Transcranial Pulse Stimulation in Alzheimer's DiseaseOct 20, 2026NCT07883148
- EXercise-induced PhysioLogical Adaptations In Neurological DisordersOct 20, 2026NCT07883720
- Remote Digital Assessments for Cognitive DisordersOct 20, 2026NCT07883746
- Cognitive Impairment and Return to Work in Long COVIDOct 19, 2026NCT07881029
- Impact of Cognitive Impairment on Chronic Pain in Breast CancerOct 16, 2026NCT07877376
- Mindfulness-Integrated Neuropsychotherapy for Traumatic Brain Injury: A Mixed-Methods Evaluation of Cognitive and Psychosocial RecoveryOct 15, 2026NCT07874685
- PICS-p Longitudinal Cohort StudyOct 15, 2026NCT07876271
- A Prospective Cohort Study of Multimodal Biomarkers and Progression From Mild Cognitive Impairment to DementiaOct 15, 2026NCT07876570
- Flutemetamol F 18 Injection Formulation ComparisonOct 14, 2026NCT07873463
- Auditory-Cognitive Optimization Care Program for Older Adults With Hearing Loss and Cognitive ImpairmentOct 13, 2026NCT07869745
- Effectiveness of a Multimodal Cognitive Rehabilitation Protocol Combined With Mechanical Periodontal Therapy in Diabetic Patients With Cognitive ImpairmentOct 13, 2026NCT07870291
- Tau Pathology in the Brain After Hip or Knee Replacement SurgeryOct 13, 2026NCT07871487
- Dyadic Cognitive Intervention for Older Adults With Cognitive Impairment and Their SpousesOct 13, 2026NCT07872189
Studies
Recruiting first, then most recently updated. Showing 50 of 3,872. Browse all 3,872 → or search them.
- Plant-based Diets and Healthy AgingRecruitingNCT071513651 country
- Temporal Interference Stimulation Targeting Thalamus for Schizophrenia-Related Cognitive DysfunctionNot yet recruitingNCT07927790Not applicable1 country
- Chinese University-Alzheimer's Disease With Vascular and Other Co-pathology: Towards Actionable Neuro-Cognitive-Omic Evaluations (CU-ADVANCE)Not yet recruitingNCT079171821 country
- PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer Disease (AD) or Mild Cognitive Impairment (MCI)RecruitingNCT07169630Phase 11 country
- Tennessee Alzheimer's ProjectRecruitingNCT053721721 country
- Effect of Long-Term Head and Neck Venous Outflow Obstruction on Cognitive Function: Evidence From Patients With Internal Jugular Vein StenosisNot yet recruitingNCT07927361
- Using Artificial Intelligence to Detect Early Signs of Alzheimer's Disease in People With Memory ConcernsNot yet recruitingNCT07652931Not applicable1 country
- Temporal Interference Stimulation Combined With Tai Chi for Mild Cognitive ImpairmentRecruitingNCT07799584Not applicable1 country
- Influence of Cognition on Activity and Participation in People With StrokeEnrolling by invitationNCT05919251Not applicable1 country
- CMN LIFU for Enhanced Amyloid Reduction (CLEART Study)RecruitingNCT07866768Not applicable1 country
- SleepSMART for Veterans With Insomnia and Mild Cognitive ImpairmentNot yet recruitingNCT07397182Not applicable1 country
- Probiotics, Cognition and Metabolic Health in Young Adults With Overweight or ObesityRecruitingNCT07073781Not applicable1 country
- Locus Coeruleus and CCHS (Congenital Central Hypoventilation Syndrome)RecruitingNCT070814641 country
- InRAD Observational StudyRecruitingNCT0721370017 countries
- HEARS-NPS: Addressing Hearing Loss as a Common Unmet Contributor of Neuropsychiatric SymptomsRecruitingNCT06930560Not applicable1 country
- Community-based Screening for Alzheimer's DiseaseRecruitingNCT075707191 country
- Telehealth-Adapted Compensatory Training and Intervention for CognitionRecruitingNCT07366346Not applicable1 country
- Mild Cognitive Impairment and NeuromodulationEnrolling by invitationNCT07691918Not applicable1 country
- Feasibility of A Smartphone Application Intervention in Community Settings: A Pretest-Posttest Pilot StudyRecruitingNCT07313540Not applicable1 country
- Prospective Research on Identification of Dementia in Early Stages (P.R.I.D.E)Not yet recruitingNCT07918638
- Flutemetamol F 18 Injection Formulation ComparisonRecruitingNCT07873463Phase 21 country
- Prediction and Prevention of Postoperative Mortality and MorbidityNot yet recruitingNCT06042413Not applicable1 country
- Neurobehavioral Changes Following Spaceflight StressorsRecruitingNCT07293494Not applicable1 country
- Treating Insomnia in Mild Cognitive ImpairmentRecruitingNCT06687161Not applicable1 country
- A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)RecruitingNCT07589595Phase 24 countries
- Photobiomodulation for Cancer-Related Cognitive ImpairmentNot yet recruitingNCT05855694Not applicable1 country
- A Study Evaluating the Impact of P-tau217 Blood Biomarker Testing on Early Evaluation and Management of Patients Presenting With Cognitive ComplaintRecruitingNCT07140744Not applicable1 country
- COG+OT Telerehabilitation for Adults With Subjective Cognitive ComplaintsNot yet recruitingNCT07743229Not applicable1 country
- A Mobile Informatics Solution to Assist Caregivers in Care Coordination and Monitoring Social EngagementNot yet recruitingNCT07773493Not applicable1 country
- A Study of LY3439539 in Participants With Alzheimer's DiseaseRecruitingNCT07598370Phase 14 countries
- Rural Veteran and Care Partner Walking ProgramRecruitingNCT07914218Not applicable1 country
- BioMIND Biospecimen RepositoryEnrolling by invitationNCT079127361 country
- China HEalthy Aging and Dementia Study (HEAD)RecruitingNCT079127101 country
- Oral Motor and Cognitive Dual-Task Training (OMCDT) Program for Improving Oral and Cognitive Functions Among People With Oral FrailtyRecruitingNCT07733726Not applicable1 country
- Assessing Treatment With High-phenolic EVOO Supplements for Neurovascular ActivityNot yet recruitingNCT07741773Not applicable1 country
- Minocycline In Neurocognitive Outcomes - Sickle Cell DiseaseNot yet recruitingNCT05605366Phase 1
- NEURO-COGS: Neurometabolic Mechanisms of Cognitive Training in SchizophreniaNot yet recruitingNCT07788755Not applicable1 country
- Transcranial Direct Current Stimulation for Chemotherapy-Related Chronic Pain in Cancer SurvivorsNot yet recruitingNCT07912775Not applicable1 country
- Small Monetary Incentives for Digital Cognitive Training Adherence in Community-Dwelling Older AdultsNot yet recruitingNCT07913243Not applicable1 country
- ENACT Program on Auditory Perception and Function, Cognitive Function and Health-related Quality of LifeRecruitingNCT06955494Not applicable1 country
- HOBSCOTCH-MS-Efficacy TrialRecruitingNCT06951919Not applicable1 country
- Buddy-Up Dyadic Physical Activity Program for Persons With Dementia and Family CaregiversRecruitingNCT06584110Not applicable1 country
- PET Imaging of Cyclooxygenases in Neurodegenerative Brain DiseaseRecruitingNCT04396873Phase 11 country
- A Prospective Study of Cognitive Changes in Retired and Late-Career Professional Soccer PlayersNot yet recruitingNCT07910994
- HOBSCOTCH-YOUTH and Young AdultsRecruitingNCT07735715Not applicable1 country
- Detecting and Predicting Post-stroke Cognitive Impairment Using the Oxford Cognitive ScreenNot yet recruitingNCT078979161 country
- Robot-Assisted Meditation for Older Adults With Cognitive ConcernsNot yet recruitingNCT07435220Not applicable
- Tau PET Outcomes With Anti-amyloid ImmunotherapiesEnrolling by invitationNCT06723015Phase 21 country
- ME/CFS Brain Fog: Cognitive Rehabilitation TrialRecruitingNCT07523113Not applicable1 country
- A First-In-Human Study of LY3954068 in Participants With Early Symptomatic Alzheimer's DiseaseRecruitingNCT06297590Phase 13 countries